Back to search

Italy· 036364038

FORBEST*AD soluz nebul 30 fiale 1 mg 1 ml

A flunisolide product containing flunisolide, registered in Italy by NEOPHARMED GENTILI SpA, on the national reimbursement list. The same ATC class is registered in 5 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC R01AD04

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · ITPublic registernormalisedFORBEST*AD soluz nebul 30 fiale 1 mg …ATCR01AD04REGISTER NO.036364038PACKS LISTED1CHECKEDJune 4, 2026

Where it is registered

Flunisolide is registered in 5 of 19 countries.

Countries holding a registration under ATC R01AD04 (flunisolide), each read from that country’s own register.

  • This record: Italy
  • 4 of them publish a price we can compare per daily dose

Flunisolide · ATC R01AD04

5 / 19 countries

  • Finlandprice
  • Germany
  • Italyprice
  • Norwayprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Active substance
Flunisolide
Manufacturer
NEOPHARMED GENTILI SpA
Country
Italy (IT)
ATC code
R01AD04
ATC class
Flunisolide
Defined daily dose
0.15 mg, N
Reimbursed
Yes
Last checked
June 4, 2026

Packs & prices · 1

1 priced
  • aic
    036364038
    FORBEST*AD soluz nebul 30 fiale 1 mg 1 ml
    EUR 26.17

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

38 interactions on record for flunisolide.

Graded by severity as the source publishes them — 38 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Flunisolide · interactions on record

38 records

  • 38 moderate

Most severe, free to view

  • MiconazoleA07AC01moderate
  • LonafarnibA16AX20moderate
  • VoxelotorB06AX03moderate
  • ConivaptanC03XA02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Flunisolide in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All flunisolide products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Germany · Syntaris

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/77c5fa06-2f86-4cd7-b7bb-59b0c3a8747b
GET /v1/drugs/77c5fa06-2f86-4cd7-b7bb-59b0c3a8747b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "price": 26.17,
  "source": "aifa",
  "currency": "EUR",
  "strength": "FLUNISOLIDE 1MG 30 UNITA' USO RESPIRATORIO",
  "substance": "Flunisolide",
  "equivalence_group": "87E",
  "transparency_flag": null
}

See everything about flunisolide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.